These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28440040)

  • 1. Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer Database.
    Mak KS; Agarwal A; Qureshi MM; Truong MT
    Cancer Med; 2017 Jun; 6(6):1192-1200. PubMed ID: 28440040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of hypofractionated radiotherapy in treatment of glioblastoma multiforme in elderly patients not receiving adjuvant chemoradiotherapy: A National Cancer Database Analysis.
    Bingham B; Patel CG; Shinohara ET; Attia A
    J Neurooncol; 2018 Jan; 136(2):385-394. PubMed ID: 29209874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.
    Haque W; Verma V; Butler EB; Teh BS
    Am J Clin Oncol; 2018 Feb; 41(2):167-172. PubMed ID: 29369825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
    Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
    J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival.
    Glaser SM; Dohopolski MJ; Balasubramani GK; Flickinger JC; Beriwal S
    J Neurooncol; 2017 Aug; 134(1):107-118. PubMed ID: 28527010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.
    Malmström A; Grønberg BH; Marosi C; Stupp R; Frappaz D; Schultz H; Abacioglu U; Tavelin B; Lhermitte B; Hegi ME; Rosell J; Henriksson R;
    Lancet Oncol; 2012 Sep; 13(9):916-26. PubMed ID: 22877848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years.
    Ohno M; Miyakita Y; Takahashi M; Igaki H; Matsushita Y; Ichimura K; Narita Y
    Radiat Oncol; 2019 Nov; 14(1):200. PubMed ID: 31718669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival in rectal cancer patients who are treated with long-course versus short-course neoadjuvant radiotherapy: A propensity-matched analysis of the NCDB.
    Chapman BC; Goodman K; Hosokawa P; Gleisner A; Cowan ML; Birnbaum E; Vogel JD
    J Surg Oncol; 2019 Mar; 119(4):518-531. PubMed ID: 30637750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis.
    Rusthoven CG; Koshy M; Sher DJ; Ney DE; Gaspar LE; Jones BL; Karam SD; Amini A; Ormond DR; Youssef AS; Kavanagh BD
    JAMA Neurol; 2016 Jul; 73(7):821-8. PubMed ID: 27214765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of hypofractionated radiation therapy in older glioblastoma patients.
    Nead KT; Swisher-McClure S
    J Geriatr Oncol; 2019 Jan; 10(1):155-158. PubMed ID: 30017732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base.
    Huang J; Samson P; Perkins SM; Ansstas G; Chheda MG; DeWees TA; Tsien CI; Robinson CG; Campian JL
    J Neurooncol; 2017 Feb; 131(3):593-601. PubMed ID: 27844308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
    Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
    World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary glioblastoma multiforme in younger patients: a single-institution experience.
    Ulutin C; Fayda M; Aksu G; Cetinayak O; Kuzhan O; Ors F; Beyzadeoglu M
    Tumori; 2006; 92(5):407-11. PubMed ID: 17168433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elderly patients with glioblastoma multiforme treated with concurrent temozolomide and standard- versus abbreviated-course radiotherapy.
    Chang-Halpenny CN; Yeh J; Lien WW
    Perm J; 2015; 19(1):15-20. PubMed ID: 25663202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.
    Hulshof MC; Koot RW; Schimmel EC; Dekker F; Bosch DA; González González D
    Strahlenther Onkol; 2001 Jun; 177(6):283-90. PubMed ID: 11446316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
    Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-escalated accelerated hypofractionation for elderly or frail patients with a newly diagnosed glioblastoma.
    Perlow HK; Yaney A; Yang M; Klamer B; Matsui J; Raval RR; Blakaj DM; Arnett A; Beyer S; Elder JB; Ammirati M; Lonser R; Hardesty D; Ong S; Giglio P; Pillainayagam C; Goranovich J; Grecula J; Chakravarti A; Gondi V; Brown PD; Palmer JD
    J Neurooncol; 2022 Jan; 156(2):399-406. PubMed ID: 35013838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-Term Outcomes and Cost-Effectiveness between Long-Course Chemoradiation and Short-Course Radiotherapy for Locally Advanced Rectal Cancer.
    Cho MS; Bae HW; Chang JS; Yang SY; Kim TH; Koom WS; Shin SJ; Choi GS; Kim NK
    Yonsei Med J; 2023 Jun; 64(6):395-403. PubMed ID: 37226566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients.
    Arvold ND; Tanguturi SK; Aizer AA; Wen PY; Reardon DA; Lee EQ; Nayak L; Christianson LW; Horvath MC; Dunn IF; Golby AJ; Johnson MD; Claus EB; Chiocca EA; Ligon KL; Alexander BM
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):384-9. PubMed ID: 25841623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.